Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pitavastatin is approved in Mexico for hyperlipidemia

Aug. 5, 2011

Development of pramlintide/metreleptin for obesity discontinued

Aug. 5, 2011

FDA grants orphan drug status to Kamada's AAT product in type 1 diabetes

Aug. 5, 2011

Prolor Biotech reports encouraging results from phase II hGH-CTP trial

Aug. 5, 2011

KBP BioSciences presents new dipeptidyl peptidase 4 inhibitors

Aug. 5, 2011

NPS Pharmaceuticals and GSK form new calcilytics agreement

Aug. 4, 2011

Zoely is approved in the E.U.

Aug. 4, 2011

Novartis enrolls patients in phase II BPS-804 trials

Aug. 4, 2011

Takeda patents new melanin-concentrating hormone MCH1 receptor antagonists

Aug. 4, 2011

Amarin completes remaining studies of AMR-101 required for NDA

Aug. 3, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...